Giacoppo S, Mandolino G, Galuppo M, et al. Cannabinoids: new promising agents in the treatment of neurological diseases[J]. Molecules, 2014, 19(11): 18781-18816. [2]Straiker A, Stella N, Piomelli D, et al. Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system[J]. Proc Natl Acad Sci U S A, 1999, 96(25): 14565-14570. [3]Middleton T P, Protti D A. Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells[J]. Vis Neurosci, 2011, 28(5): 393-402. [4]Xie S, Furjanic M A, Ferrara J J, et al. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism——or inverse agonism——as potential obesity treatment and other therapeutic use[J]. J Clin Pharm Ther, 2007, 32(3): 209-231. [5]Nucci C, Gasperi V, Tartaglione R, et al. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats[J]. Invest Ophthalmol Vis Sci, 2007, 48(7): 2997-3004. [6]Hashimotodani Y, Ohno-Shosaku T, Kano M. Endocannabinoids and synaptic function in the CNS[J]. Neuroscientist, 2007, 13(2): 127-137. [7]Araya K A, David-Pessoa-Mahana C, Gonzalez L G. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na？+, K？+-ATPase activity by WIN55, 212-2 and delta(9)-THC[J]. Eur J Pharmacol, 2007, 572(1): 32-39. [8]Yazulla S. Endocannabinoids in the retina: from marijuana to neuroprotection[J]. Prog Retin Eye Res, 2008, 27(5): 501-526. [9]McMahon D G, Iuvone P M, Tosini G. Circadian organization of the mammalian retina: from gene regulation to physiology and diseases[J]. Prog Retin Eye Res, 2014, 39: 58-76. [10]Li Z W, Zhang J, Ouyang C H, et al. Potentiation by WIN 55, 212-2 of GABA-activated currents in rat trigeminal ganglion neurones[J]. Br J Pharmacol, 2009, 158(8): 1904-1910. [11]Yang X L, Gao F, Wu S M. Modulation of horizontal cell function by GABA(A) and GABA(C) receptors in dark- and light-adapted tiger salamander retina[J]. Vis Neurosci, 1999, 16(5): 967-979. [12]Schlicker E, Timm J, Gothert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina[J]. Naunyn Schmiedebergs Arch Pharmacol, 1996, 354(6): 791-795. [13]汪书越, 李玲竹, 苗艳颖, 等. 大麻素受体在大鼠视网膜中的表达和分布[J]. 中国眼耳鼻喉科杂志, 2014, 14(4): 205-210. [14]Wang X H, Wu Y, Yang X F, et al. Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory synaptic transmission in rat inner retina[J]. Brain Struct Funct, 2014, [Epub ahead of print]. [15]Zhang C Q, Wu H J, Wang S Y, et al. Suppression of outward K？+ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors[J]. Neuroscience, 2013, 253: 183-193. [16]Lalonde M R, Jollimore C A, Stevens K, et al. Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells[J]. Mol Vis, 2006, 12: 1160-1166. [17]Katona I, Freund T F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease[J]. Nat Med, 2008, 14(9): 923-930.
